Literature DB >> 3075588

Antigen-presenting function of B lymphocytes.

S K Pierce1, J F Morris, M J Grusby, P Kaumaya, A van Buskirk, M Srinivasan, B Crump, L A Smolenski.   

Abstract

Here we review our current results studying B cells as APC and the mechanisms by which processed antigen is transported to and held on the cell surface for recognition by the specific T cell along with the MHC class II molecules. These studies were carried out using the globular protein cytochrome c as antigen for which the T-cell antigenic determinant was localized to a C-terminal 10-amino acid peptide fragment. For certain analyses, native cytochrome c or antigenic peptide fragments were covalently coupled to antibodies directed toward B-cell surface structures, allowing the targeting of antigen to the APC surface. Our findings indicate that all B cells function as APC and that the APC function is not differentially regulated in defined B-cell subpopulations. Using cytochrome c-antibody conjugates, it was shown that the surface Ig plays two significant roles in augmenting the B-cell APC function following antigen binding: signalling for enhanced APC function and concentrating antigen for subsequent internalization and processing. Both IgM and IgD appear to function identically in facilitating antigen processing in both immune and nonimmune B-cell populations. Furthermore, the surface Ig does not appear to be specially differentiated to function in concentrating antigen, as antigen artificially bound to other B-cell surface structures including MHC class I and class II molecules is also effectively presented. Lastly, evidence is presented that a previously described B-cell activating factor activity is strongly associated with the membranes of activated but not unactivated helper T cells, providing a mechanism by which the T-cell helper function can be focused on the specific antigen-presenting B cell. Concerning the mechanism by which processed antigen is presented at the B-cell surface, evidence is presented suggesting a role of peptide-binding chaperone proteins which may function to transport peptide to the APC surface and facilitate its association with the appropriate Ia. One candidate protein, PBP72/74, is described which binds peptides but not native antigens, is a member of the hsp70 family and appears to play a role in antigen presentation by the ability of antisera raised against it to block APC functions. Peptide-antibody conjugates were used to explore the spacial restrictions on MHC-restricted peptide presentation and it was shown that peptides covalently coupled to antibodies specific for Ig, class I or class II molecules are effective antigens in vitro even in the absence of processing.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3075588     DOI: 10.1111/j.1600-065x.1988.tb00778.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  29 in total

Review 1.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

Review 2.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

3.  Characterization of naturally processed antigen bound to major histocompatibility complex class II molecules.

Authors:  M Srinivasan; E W Marsh; S K Pierce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  Antigen-presenting cells in draining lymph nodes of goats repeatedly infested by the Cayenne tick Amblyomma cajennense nymphs.

Authors:  Gaby Ermelindo Roberto Monteiro; Gervásio Henrique Bechara; Alessandra Maria Franzin; Isabel Kinney Ferreira de Miranda Santos
Journal:  Exp Appl Acarol       Date:  2010-07-02       Impact factor: 2.132

5.  Inhibition of antigen trafficking through scavenger receptor A.

Authors:  Maurice T Raycroft; Bohdan P Harvey; Matthew J Bruck; Mark J Mamula
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

Review 6.  Reprogramming of B cells into regulatory cells with engineered fusokines.

Authors:  Jiusheng Deng; Jacques Galipeau
Journal:  Infect Disord Drug Targets       Date:  2012-06

Review 7.  Specific immunotherapy of cancer in elderly patients.

Authors:  S Matzku; M Zöller
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 8.  The role of B cells in the immunopathogenesis of multiple sclerosis.

Authors:  Tohid Gharibi; Zohreh Babaloo; Arezoo Hosseini; Faroogh Marofi; Abbas Ebrahimi-Kalan; Saeed Jahandideh; Behzad Baradaran
Journal:  Immunology       Date:  2020-05-10       Impact factor: 7.397

9.  Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors.

Authors:  Bohdan P Harvey; Timothy E Quan; Benjamin J Rudenga; Robert M Roman; Joe Craft; Mark J Mamula
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate.

Authors:  A M Montgomery; M G Wing; P J Lachmann
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.